ROYAL BANK OF CANADA - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$191,000
+13.7%
42,020
+77.0%
0.00%
Q2 2023$168,000
+147.1%
23,740
+112.2%
0.00%
Q1 2023$68,000
-54.7%
11,190
-52.5%
0.00%
Q4 2022$150,000
+212.5%
23,580
+365.5%
0.00%
Q3 2022$48,000
+33.3%
5,066
+54.5%
0.00%
Q2 2022$36,000
-66.4%
3,279
-49.2%
0.00%
Q1 2022$107,000
-18.9%
6,454
-6.7%
0.00%
Q4 2021$132,000
-32.3%
6,915
-13.0%
0.00%
Q3 2021$195,000
-78.1%
7,949
-76.8%
0.00%
Q2 2021$892,000
+1089.3%
34,273
+1357.2%
0.00%
Q1 2021$75,000
-73.8%
2,352
-61.9%
0.00%
Q4 2020$286,000
-95.1%
6,177
-96.5%
0.00%
-100.0%
Q3 2020$5,825,000
+36.6%
176,967
+13.9%
0.00%0.0%
Q2 2020$4,265,000
+33.0%
155,431
+45.2%
0.00%0.0%
Q1 2020$3,206,000
+245.1%
107,073
+219.1%
0.00%
Q4 2019$929,000
+144.5%
33,559
+60.6%
0.00%
Q3 2019$380,000
+874.4%
20,895
+1205.9%
0.00%
Q2 2019$39,000
+95.0%
1,600
-23.8%
0.00%
Q1 2019$20,000
+42.9%
2,100
+36.8%
0.00%
Q4 2018$14,000
-66.7%
1,535
-58.4%
0.00%
Q3 2018$42,000
+110.0%
3,690
+134.7%
0.00%
Q2 2018$20,000
-61.5%
1,572
-48.9%
0.00%
Q1 2018$52,000
+477.8%
3,076
+188.0%
0.00%
Q4 2017$9,000
-82.0%
1,068
-83.2%
0.00%
Q3 2017$50,000
+733.3%
6,341
+645.1%
0.00%
Q2 2017$6,0008510.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders